Home/Filings/4/0001213900-26-001394
4//SEC Filing

Manieu Alexandre Weinstein 4

Accession 0001213900-26-001394

CIK 0001158780other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:43 PM ET

Size

41.4 KB

Accession

0001213900-26-001394

Insider Transaction Report

Form 4
Period: 2025-12-30
Transactions
  • Award

    Common Stock

    2025-12-08$2.00/sh+625,000$1,250,000625,000 total(indirect: Shares indirectly held through Chutzpah Holdings LP)
  • Award

    Warrants

    2025-12-08$2.00/sh+625,000$1,250,000625,000 total(indirect: Warrants indirectly held through Chutzpah Holdings LP)
    Exercise: $4.25From: 2025-12-08Exp: 2026-06-30Common Shares (625,000 underlying)
Holdings
  • Common Stock

    (indirect: Shares indirectly held through Plantae Bioscience Ltd.)
    452,702
Transactions
  • Award

    Common Stock

    2025-12-08$2.00/sh+625,000$1,250,000625,000 total(indirect: Shares indirectly held through Chutzpah Holdings LP)
  • Award

    Warrants

    2025-12-08$2.00/sh+625,000$1,250,000625,000 total(indirect: Warrants indirectly held through Chutzpah Holdings LP)
    Exercise: $4.25From: 2025-12-08Exp: 2026-06-30Common Shares (625,000 underlying)
Holdings
  • Common Stock

    (indirect: Shares indirectly held through Plantae Bioscience Ltd.)
    452,702
Footnotes (4)
  • [F1]On December 8, 2025, Pluri Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Chutzpah Holdings LP, a limited partnership beneficially owned by Mr. Alexandre Weinstein, a non-U.S. investor and an existing shareholder and director of the Company ("Mr. Weinstein"), relating to a private placement offering (the "Offering") of: (i) 625,000 common shares, par value $0.00001 per share (the "Common Shares") of the Company, and (ii) warrants (the "Common Warrants") to purchase up to 625,000 Common Shares. The combined purchase price for each Common Share and Common Warrant is $4.00.
  • [F2](Continuation of Footnote 1) The Common Warrants will be exercisable immediately at an exercise price of $4.25 per share and will be exercisable until June 30, 2026. The Common Warrants contain customary anti-dilution provisions and are subject to a 35% beneficial ownership limitation. The Securities Purchase Agreement contains customary representations, warranties and indemnification obligations of the parties.
  • [F3]This statement is jointly filed by and on behalf of each of Chutzpah Holdings LP ("CHLP"), Chutzpah Holdings Limited ("CHL"), Plantae Bioscience Ltd. ("Plantae") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.
  • [F4]Mr. Weinstein indirectly owns approximately 78.32% of PBL and may be deemed to beneficially own securities owned by PBL. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by PBL. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

Issuer

Pluri Inc.

CIK 0001158780

Entity typeother

Related Parties

1
  • filerCIK 0001833124

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:43 PM ET
Size
41.4 KB